Evaluation of the impact of a nurse-led telephone follow-up on treatment compliance of patients treated from a locally advanced or metastatic non-small-cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation(s).The PARTAGE study.

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/12955
• EU PAS number:
  EUPAS12954
• Study ID:
  12955
• Official title and acronym:
  Evaluation of the impact of a nurse-led telephone follow-up on treatment compliance of patients treated from a locally advanced or metastatic non-small-cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation(s).The PARTAGE study.
• DARWIN EU® study:
  No
• Study countries:
  France
• Study description:
  Evaluation of the impact of nurse-led telephone on treatment compliance
• Study status:
  Ongoing

Research institutions and networks

Institutions

Hôpital Européen Georges Pompidou

Study timelines

Date when funding contract was signed

Planned: 18/12/2015

Actual: 18/12/2015

Study start date

Planned: 15/10/2015

Actual: 18/12/2015

Data analysis start date

Planned: 18/06/2018

Date of final study report

Planned: 18/03/2019

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Boehringer

Regulatory

• Was the study required by a regulatory body?:
  No